lomustine has been researched along with Cancer of the Urinary Tract in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " An important cause of reduced benefit from chemotherapy among elderly patients may be the reduced dosage of cisplatin." | 1.28 | Cisplatin combination chemotherapy for elderly patients with urothelial tumours. ( Amato, R; Dexeus, FH; Finn, L; Fitz, K; Logothetis, CJ; Sella, A, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sella, A | 1 |
| Logothetis, CJ | 1 |
| Dexeus, FH | 1 |
| Amato, R | 1 |
| Finn, L | 1 |
| Fitz, K | 1 |
1 other study available for lomustine and Cancer of the Urinary Tract
| Article | Year |
|---|---|
Cisplatin combination chemotherapy for elderly patients with urothelial tumours.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cel | 1991 |